Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Control of TH17 cells occurs in the small intestine.
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical Phenotypes.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
[Neuromyelitis optica spectrum disorder: a case report].
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Transcriptomic meta-analysis of multiple sclerosis and its experimental models.
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Pages
« first
‹ previous
…
218
219
220
221
222
223
224
225
226
…
next ›
last »